Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Lignocaine for Hemodynamic Response in Laparoscopic Cholecystectomy
NCT07192081Recruiting
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of labetalol in hemodynamic instability (2 arms). Primary endpoint: Change in Systolic Blood Pressure Following Laryngoscopy. Started Jun 2025; status: recruiting.
02
Drugs
labetalol
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT07192081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07192081.